Charles River to Acquire Argenta and BioFocus from Galapagos

News   Mar 13, 2014

 
Charles River to Acquire Argenta and BioFocus from Galapagos
 
 
 

RELATED ARTICLES

170 Potential Lung Cancer Drug Targets Identified Using Unique Cellular Library

News

After testing more than 200,000 chemical compounds, UT Southwestern’s Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

READ MORE

Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening

News

A multidisciplinary team of scientists share recent advancements in innovative in-vitro cancer biology methods for screening drug-like molecules in cancer tissue relevant models in a new report published online ahead-of-print at SLAS Discovery.

READ MORE

Fermentation Byproduct Suppresses Seizures in Nerve Agent Poisoning

News

A compound found in trace amounts in alcoholic beverages is more effective at combating seizures in rats exposed to an organophosphate nerve agent than the current recommended treatment.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE